Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Australia Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20072
20082
20091
20101
20112
20121
20131
20172
20181
20192
20201
20212
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
GlaxoSmithKline4
Pfizer4
Novartis Pharmaceuticals3
Pearl Therapeutics, Inc.2
Aquinox Pharmaceuticals (Canada) Inc.1
Connect Biopharm LLC1
Genentech, Inc.1
Macquarie University, Australia1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive25
Bronchiolitis Obliterans Syndrome2
Bronchitis1
Bronchitis, Chronic1
Emphysema1
Hypertension, Pulmonary1
Inflammation1
Respiration Disorders1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.